Page last updated: 2024-08-23

pirfenidone and Hyperplasia

pirfenidone has been researched along with Hyperplasia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Deng, Y; Kong, J	1
Margolin, SB; Metcalfe, MS; Nicholson, ML; Toomey, D; Waller, JR	1
Gelfand, EW; Hirano, A; Ito, W; Kanehiro, A; Kataoka, M; Nakashima, H; Okada, C; Ono, K; Tanimoto, M; Tanimoto, Y; Yoshida, A	1

Trials

1 trial(s) available for pirfenidone and Hyperplasia

Article	Year
Pirfenidone alleviates vascular intima injury caused by hyperhomocysteinemia. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2022, Volume: 41, Issue:10 Topics: Animals; Antioxidants; Glutathione Peroxidase; Homocysteine; Hyperhomocysteinemia; Hyperplasia; Lipids; Malondialdehyde; Methionine; Oxidants; Pyridones; Rabbits; Reactive Oxygen Species; Superoxide Dismutase; Tunica Intima	2022

Article

Year

Pirfenidone alleviates vascular intima injury caused by hyperhomocysteinemia.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2022, Volume: 41, Issue:10

Topics: Animals; Antioxidants; Glutathione Peroxidase; Homocysteine; Hyperhomocysteinemia; Hyperplasia; Lipids; Malondialdehyde; Methionine; Oxidants; Pyridones; Rabbits; Reactive Oxygen Species; Superoxide Dismutase; Tunica Intima

2022

Other Studies

2 other study(ies) available for pirfenidone and Hyperplasia

Article	Year
Pirfenidone inhibits early neointimal proliferation following arterial injury. Transplantation proceedings, 2002, Volume: 34, Issue:5 Topics: Animal Feed; Animals; Cell Division; Dietary Supplements; Hyperplasia; Male; Muscle, Smooth, Vascular; Postoperative Complications; Pyridones; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tunica Intima; Vascular Diseases	2002
Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge. American journal of respiratory cell and molecular biology, 2006, Volume: 35, Issue:3 Topics: Allergens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cell Proliferation; Cytokines; Eosinophils; Goblet Cells; Hyperplasia; Immunoglobulin E; Interleukin-13; Interleukin-4; Interleukin-5; Leukocytes, Mononuclear; Lymphocytes; Mice; Mice, Inbred BALB C; Ovalbumin; Platelet-Derived Growth Factor; Pyridones; Transforming Growth Factor beta; Transforming Growth Factor beta1	2006

Article

Year

Pirfenidone inhibits early neointimal proliferation following arterial injury.

Transplantation proceedings, 2002, Volume: 34, Issue:5

Topics: Animal Feed; Animals; Cell Division; Dietary Supplements; Hyperplasia; Male; Muscle, Smooth, Vascular; Postoperative Complications; Pyridones; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tunica Intima; Vascular Diseases

2002

Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge.

American journal of respiratory cell and molecular biology, 2006, Volume: 35, Issue:3

Topics: Allergens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cell Proliferation; Cytokines; Eosinophils; Goblet Cells; Hyperplasia; Immunoglobulin E; Interleukin-13; Interleukin-4; Interleukin-5; Leukocytes, Mononuclear; Lymphocytes; Mice; Mice, Inbred BALB C; Ovalbumin; Platelet-Derived Growth Factor; Pyridones; Transforming Growth Factor beta; Transforming Growth Factor beta1

2006